Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
暂无分享,去创建一个
J. Downing | F. Behm | S. Raimondi | C. Pui | J. Shuster | M. Link | M. Borowitz | A. Carroll | J. Rubnitz | B. Camitta | D. Pullen | H. Mahmoud
[1] A. Hagemeijer,et al. The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients , 1998, Leukemia.
[2] B. Johansson,et al. Hematologic malignancies with t(4;11)(q21;q23) – a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases , 1998, Leukemia.
[3] F. Behm,et al. Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII , 1997, Leukemia.
[4] M. Cleary,et al. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL , 1997, The EMBO journal.
[5] C. Caldas,et al. EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] H. Sather,et al. CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study , 1996 .
[7] M. Seto,et al. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia. , 1996, Leukemia.
[8] J. Downing,et al. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias. , 1996, Blood.
[9] J. Downing,et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. , 1996, Blood.
[10] F. Behm,et al. 11q23 rearrangements in acute leukemia. , 1996, Leukemia.
[11] Y. Yazaki,et al. Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation. , 1995, Blood.
[12] F. Lo Coco,et al. Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias. , 1995, Leukemia.
[13] J. Rowley,et al. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Cleary,et al. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. , 1994, Blood.
[15] J. Shuster,et al. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1994, Blood.
[16] J. Downing,et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] S. Raimondi,et al. Childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): an update [letter] , 1994 .
[18] N. Heerema,et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group. , 1994, Blood.
[19] J. Rowley,et al. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA- topoisomerase II , 1993 .
[20] S. Korsmeyer,et al. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[21] F. Behm,et al. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. , 1993, Blood.
[22] C. Croce,et al. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. , 1993, Blood.
[23] F. Behm,et al. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. , 1993, Blood.
[24] M. Amylon,et al. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. , 1993, Blood.
[25] S. Korsmeyer,et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. , 1993, Blood.
[26] U. Francke,et al. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. , 1993, Blood.
[27] J. Huret,et al. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations. , 1993, Leukemia.
[28] C. Pui,et al. Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. , 1993, Leukemia.
[29] H. Alder,et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene , 1992, Cell.
[30] Michael L. Cleary,et al. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias , 1992, Cell.
[31] G. Evans,et al. A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias , 1992, Nature Genetics.
[32] Y. Akao,et al. Rearrangements on chromosome 11q23 in hematopoietic tumor-associated t(11;14) and t(11;19) translocations. , 1991, Cancer research.
[33] J. Rowley,et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[34] J J Shuster,et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. , 1991, Blood.
[35] A. Look,et al. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Jonathan J. Shuster,et al. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study , 1990 .
[37] Jonathan J. Shuster,et al. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study , 1990 .
[38] F. Behm,et al. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. , 1990, Blood.
[39] F. Behm,et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. , 1989, The New England journal of medicine.
[40] D. Williams,et al. A direct bone marrow chromosome technique for acute lymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.
[41] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[42] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .